The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study
- PMID: 36843591
- PMCID: PMC9948618
- DOI: 10.3389/fendo.2023.1072288
The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study
Abstract
Objective: Chronic hyperglycemia induces pathogenic changes in the vascular endothelium and leads to the development of microvascular complications in patients with type 2 diabetes mellitus. Early identification of markers of diabetes complications may help to minimize the risk of the development and progression of microvascular complications.
Methods: This follow-up study was conducted in type 2 diabetic cohort aged between 30-70 years. Out of 160 eligible participants, 70 of them completed follow-up. Levels of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin and P-selectin) at baseline and follow-up were measured using Randox Evidence biochip analyzer (UK). Development of microvascular complications (diabetic neuropathy, retinopathy and nephropathy) was evaluated.
Results: During the follow-up (2 years, median), 31 (44.3%) developed diabetic neuropathy, 10 (14.3%) developed diabetic retinopathy and, 27 (38.6%) developed diabetic nephropathy. A significant difference in levels of cell adhesion molecules and selectins were found in type 2 diabetic patients with and without microvascular complications. Multiple logistic regression analysis reveals that baseline level of VCAM-1 is significantly associated with microvascular complications; diabetic neuropathy(p=0.028), retinopathy (p=0.007) and nephropathy(p=<0.001). Additionally, levels of P-selectin (p=0.05) and L-selectin (p=0.008) is associated with diabetic nephropathy while retinopathy associated with L-selectin (p=0.005) only.
Conclusion: Cell adhesion molecules and selectins are indicators of microvascular complication among patients with type 2 diabetes (T2D). Association of these markers with the development of microvascular complications may provide additive information for developing strategies for diabetes management and prediction of microvascular complications.
Keywords: adhesion molecule; complications; diabetic nephropathy; diabetic neuropathy; diabetic retinopathy.
Copyright © 2023 Siddiqui, George, Mujammami, Isnani and Alfadda.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study.Pediatr Diabetes. 2020 Sep;21(6):923-931. doi: 10.1111/pedi.13062. Epub 2020 Jul 2. Pediatr Diabetes. 2020. PMID: 32501612 Free PMC article. Clinical Trial.
-
Levels of adhesion molecules in peripheral blood correlat with stages of diabetic retinopathy and may serve as bio markers for microvascular complications.Cytokine. 2018 Jun;106:76-79. doi: 10.1016/j.cyto.2017.10.014. Epub 2017 Nov 11. Cytokine. 2018. PMID: 29133026
-
Are soluble E-selectin, ICAM-1, and VCAM-1 potential predictors for the development of diabetic retinopathy in young adults, 15-34 years of age? A Swedish prospective cohort study.PLoS One. 2024 Jun 6;19(6):e0304173. doi: 10.1371/journal.pone.0304173. eCollection 2024. PLoS One. 2024. PMID: 38843125 Free PMC article.
-
[Adhesion molecules in type 2 diabetes].Przegl Lek. 2005;62(4):234-7. Przegl Lek. 2005. PMID: 16229242 Review. Polish.
-
The pathophysiological role of circulating adhesion molecules in schizophrenia: A systematic review and meta-analysis.Schizophr Res. 2024 Feb;264:157-169. doi: 10.1016/j.schres.2023.12.025. Epub 2023 Dec 26. Schizophr Res. 2024. PMID: 38150848
Cited by
-
The Effect of Autologous Dendritic Cell Immunotherapy on Kidney Function and Endothelial Dysfunction of Patients with Diabetic Kidney Disease (DKD): An Open Label Clinical Trial.Curr Issues Mol Biol. 2025 Jan 6;47(1):31. doi: 10.3390/cimb47010031. Curr Issues Mol Biol. 2025. PMID: 39852146 Free PMC article.
-
The mineralocorticoid receptor in diabetic kidney disease.Am J Physiol Renal Physiol. 2024 Sep 1;327(3):F519-F531. doi: 10.1152/ajprenal.00135.2024. Epub 2024 Jul 18. Am J Physiol Renal Physiol. 2024. PMID: 39024357 Free PMC article. Review.
-
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.Cardiovasc Diabetol. 2024 Feb 20;23(1):75. doi: 10.1186/s12933-023-02097-8. Cardiovasc Diabetol. 2024. PMID: 38378550 Free PMC article. Review.
-
Molecular basis of cardioprotective effects of methanol extract of Ficus exasperata in diabetic Wistar rats.Toxicol Rep. 2025 Apr 18;14:102028. doi: 10.1016/j.toxrep.2025.102028. eCollection 2025 Jun. Toxicol Rep. 2025. PMID: 40353243 Free PMC article.
-
Causal Effects of Oxidative Stress on Diabetes Mellitus and Microvascular Complications: Insights Integrating Genome-Wide Mendelian Randomization, DNA Methylation, and Proteome.Antioxidants (Basel). 2024 Jul 26;13(8):903. doi: 10.3390/antiox13080903. Antioxidants (Basel). 2024. PMID: 39199149 Free PMC article.
References
-
- International Diabetes Federation . IDF diabetes atlas, 9th ed international diabetes federation, Brussels (2019). Available at: http://www.diabetesatlas.org (Accessed July 8, 2021).
-
- Zoungas S, Arima H, Gerstein HC, Holman RR, Woodward M, Reaven P, et al. . Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: A meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol (2017) 5:431–7. doi: 10.1016/S2213-8587(17)30104-3 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous